Jump to content

Main menu Navigation ●Main page ●Contents ●Current events ●Random article ●About Wikipedia ●Contact us ●Donate Contribute ●Help ●Learn to edit ●Community portal ●Recent changes ●Upload file

●Create account ●Log in ●Create account ● Log in Pages for logged out editors learn more ●Contributions ●Talk

(Top) 1 References

Pyronaridine

●العربية ●Polski ●Српски / srpski ●Srpskohrvatski / српскохрватски ●Suomi ●Tiếng Việt ●中文 Edit links ●Article ●Talk ●Read ●Edit ●View history Tools Actions ●Read ●Edit ●View history General ●What links here ●Related changes ●Upload file ●Special pages ●Permanent link ●Page information ●Cite this page ●Get shortened URL ●Download QR code ●Wikidata item Print/export ●Download as PDF ●Printable version Appearance From Wikipedia, the free encyclopedia

Pyronaridine
Clinical data

Other names	Pyronaridine tetraphosphate
Routes of administration	Oral, intramuscular injection, intravenous therapy
ATC code	none
Legal status
Legal status	CLP (EU): Acute Tox. 3(H301), Eye Dam. 1 (H318), Repr. 2 (H361), Aquatic Chronic 4 (H413)^{[clarification needed]}
Identifiers
IUPAC name 4-[(7-Chloro-2-methoxy-pyrido[3,2-b]quinolin-10-yl)amino]-2,6-bis(pyrrolidin-1-ylmethyl)phenol
CAS Number	74847-35-1^N
PubChem CID	5485198
ChemSpider	10647812^Y
UNII	TD3P7Q3SG6
ChEMBL	ChEMBL35228^Y
CompTox Dashboard (EPA)	DTXSID60996354
Chemical and physical data
Formula	C₂₉H₃₂ClN₅O₂
Molar mass	518.06 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES Clc1ccc6c(c1)nc2ccc(OC)nc2c6Nc5cc(CN3CCCC3)c(O)c(CN4CCCC4)c5
InChI InChI=1S/C29H32ClN5O2/c1-37-26-9-8-24-28(33-26)27(23-7-6-21(30)16-25(23)32-24)31-22-14-19(17-34-10-2-3-11-34)29(36)20(15-22)18-35-12-4-5-13-35/h6-9,14-16,36H,2-5,10-13,17-18H2,1H3,(H,31,32)^Y Key:DJUFPMUQJKWIJB-UHFFFAOYSA-N^Y
^NY (what is this?) (verify)

Pyronaridine is an antimalarial drug.^[1] It was first made in 1970 and has been in clinical use in China since the 1980s.^[2]

In a small (n=88) malaria study in Camaroon, pyronaridine had a 100% cure rate, compared with 60% for chloroquine.^[3]

It is one of the components of the artemisinin combination therapy pyronaridine/artesunate (Pyramax).^[4]

It has also been studied as a potential anticancer drug,^[5] and treatment for Ebola. The combination of pyronaridine and artesunate has been evaluated to have a synergistic effect of stronger antiviral effect and less toxicity.^[6] The combination of pyronaridine and artesunate is being studied as a possible treatment for moderate to severe SARS-COV-2.^[7]

References

[edit]

^ Croft SL, Duparc S, Arbe-Barnes SJ, Craft JC, Shin CS, Fleckenstein L, et al. (August 2012). "Review of pyronaridine anti-malarial properties and product characteristics". Malaria Journal. 11: 270. doi:10.1186/1475-2875-11-270. PMC 3483207. PMID 22877082.

^ Chang C, Lin-Hua T, Jantanavivat C (1992). "Studies on a new antimalarial compound: pyronaridine". Transactions of the Royal Society of Tropical Medicine and Hygiene. 86 (1): 7–10. doi:10.1016/0035-9203(92)90414-8. PMID 1566313.